Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 314
Summary
- Conditions
- Elderly
- SARS CoV-2 Infection
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Other
Participation Requirements
- Age
- Between 60 years and 125 years
- Gender
- Both males and females
Description
The working hypothesis is that the administration of a Lactobacillus strain improves the immune response in the elderly population, improving the immune response to a possible COVID-19 infection. The strain would act as an adjuvant that contributes to developing an effective response against the vir...
The working hypothesis is that the administration of a Lactobacillus strain improves the immune response in the elderly population, improving the immune response to a possible COVID-19 infection. The strain would act as an adjuvant that contributes to developing an effective response against the virus, and therefore there are fewer infectious symptoms due to this virus or, if it appears, it occurs in a milder way among the subjects who take the probiotic strain. Also,the investigators hypothesizes that the administration of the Lactobacillus may improve the immune response generated by the Covid-19 vaccine in this elderly population.
Tracking Information
- NCT #
- NCT04756466
- Collaborators
- Not Provided
- Investigators
- Study Director: Mónica Olivares, PhD Biosearch S.A. Principal Investigator: Anxo Fernandez-Ferreiro, PhD Complejo Hospitalario Universitario de Santiago Compostela
Get Well Soon